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Background: Osteoporosis-related fractures represent a major health 
problem. Although spine and hip bone densitometry is the gold standard 
to assess bone density, this test is not always accesible. The purpose of 
this study was to describe two options to assess the risk of fracture due 
to osteoporosis in post-menopausal women assigned to a primary care 
unit where bone densitometry is not available.
Methods: A cross-sectional study was conducted in 332 post-meno-
pausal women without diagnosis or treatment for osteoporosis, attend-
ing regularly to a primary care unit. A heel bone peripheral densitometry, 
physical exam and medical history were performed. The assessment of 
fracture risk was carried out using the FRAX™ method.
Results: Mean age was 60 ± 8.7 years and body mass index was 
28.68 ± 4.24. According to the heel bone peripheral densitometry, 19 
(5.7 %) women had osteoporosis (T-score less than or equal to –2.5), 
171 (51.8 %) had osteopenia (T-score between –2.5 and less than or 
equal to –1) and 141 (42.5 %) had normal bone mineral density. Accord-
ing to the FRAX method, 13 (3.9 %) had an increased risk of osteoporotic 
fracture in a 10-year period and 40 (12 %) of hip fracture.
Conclusions: There was low concordance in the 10-year risk for major 
osteoporotic fracture and hip fracture assessed with both the FRAX™ 
and the peripheral bone densitometry methods.
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Osteoporosis is the most common metabolic bone disease. It affects up to 40 % of post-menopausal women. Osteoporosis is con-
sidered a silent disease because bone loss occurs 
without symptoms or signs. Approximately two-thirds 
of vertebral fractures are asymptomatic. In many 
cases clinical osteoporosis is recognized by the occur-
rence of fracture after minimal trauma.1 The number 
of elderly individuals is increasing with the rising of 
life expectancy worldwide. It has been estimated that 
the incidence of hip fracture will rise from 1.66 mil-
lion in 1990 to 6.26 million by 2050.2 Annual rate of 
hip fracture published in 2005 by the two main public 
health care systems of Mexico, was 169 in women and 
98 in men per 10 000 person-year; that corresponds to 
one out of every 12 women 50 year-old in Mexico will 
have a hip fracture. It has been estimated that the cost 
of treatment of osteoporotic fracture per year is more 
than 36 million dollars for one of the most important 
Mexican health care system.3
The bone mineral density (BMD) measurements 
have an important role in the evaluation of patients at 
risk of osteoporosis. The preferred method of testing 
is the central dual energy X-ray absorptiometry scan 
(DXAS) to measure BMD of the lumbar spine and hip. 
The T-score defi nition obtained by the DXAS measure 
is considered the gold standard in the diagnosis of osteo-
porosis for the World Health Organization.4 However, 
DXAS scan has two problems for developing countries: 
the cost and the unavailability of the equipment in many 
little localities, especially in poorer rural areas.5
In recent years the World Health Organization had 
proposed the use of a fracture risk assessment tool 
(FRAXTM) for individual estimation of 10-year major 
osteoporotic and hip fracture probabilities.6 This has 
led to broad endorsement of FRAXTM and its inte-
gration into several clinical practice guidelines. For 
example, subjects with a 10-year major osteoporotic 
fracture probability greater than or equal to 20 % or 
3 % for hip fracture are considered an indication for 
intervention according to the National Osteoporosis 
Foundation (NOF).7 The World Health Organization 
has proposed that FRAXTM could be used without 
BMD value in that regions where DXAS is not avail-
able and it is an alternative approach to evaluate peo-
ple at risk of osteoporotic fracture.
Resumen
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Introducción: las fracturas relacionadas con la osteo-
porosis son un problema de salud. Aunque la densito-
metría ósea de columna y cadera es el estándar para 
evaluar la densidad ósea, no siempre es accesible. El 
objetivo de este estudio fue describir dos alternativas 
a la densitometría ósea para evaluar el riesgo de frac-
tura por osteoporosis en mujeres posmenopáusicas.
Métodos: estudio transversal de 332 mujeres posme-
nopáusicas sin diagnóstico o tratamiento de osteoporo-
sis, que asistían regularmente a una unidad de primer 
nivel. Se realizó densitometría periférica de talón, exa-
men físico e historia médica. La evaluación del riesgo 
de fractura se llevó a cabo mediante FRAXTM.
Resultados: la edad media fue de 60 ± 8.7 años y 
el índice de masa corporal de 28.68 ± 4.24. Según la 
densitometría periférica de talón, mujeres 19 (5.7 %) 
tenían osteoporosis (T-score menor de –2.5), 171 
(51.8 %) osteopenia (T-score entre –2.5 y menos de 
–1) y 141 (42.5 %) densidad mineral ósea normal. 
Según el método FRAX, 13 (3.9 %) tenían riesgo 
aumentado de fractura osteoporótica en un periodo de 
10 años y 40 (12 %) de fractura de cadera.
Conclusiones: la prevalencia de riesgo para osteo-
porosis es diferente de acuerdo con el método que 
se utilice para medirlo. La concordancia entre los dos 
métodos fue baja.
Because osteoporosis is common and usually it is 
managed in primary care, a cheap and suitable method 
of evaluating osteoporosis risk fracture without BMD 
is necessary.5,8 Peripheral dual energy X-ray absorpti-
ometry scan (pDXAS) might fulfi ll this role, pDXAS 
is an established method of assessing skeletal status, 
and with the advantages of low cost and portability, it 
is recognized as an alternative tool for identifying indi-
viduals at risk of fracture.9 It is accepted that osteopo-
rosis could not be diagnosed with pDXAS, however 
this tool has the advantage over central DXAS that 
is cheaper, transportable and use less ionizing radia-
tion. The low cost and easy transportability become 
pDXAS in an useful tool in the osteoporosis detection 
when cost or instrument inaccessibility to a central 
DXAS is diffi cult or impossible.10,11 The primary care 
is the best opportunity to prevent osteoporotic frac-
tures in postmenopausal women, unfortunately the 
decision of beginning therapy at primary care unit is 
diffi cult, the most of the times has to be done without 
central DXAS results. The aim of this study was to 
describe two different approaches in the evaluation of 
osteoporosis risk fracture in postmenopausal women 
attending a primary care level unit, where central 
DXAS is not available to measure central BMD.
Methods
All participants were consecutive, unselected post-
menopausal women. Who assisted for general medical 
check in the Primary Care Unit # 222 in the Instituto 
Mexicano del Seguro Social (IMSS), Toluca, Mexico, 
between 2009 and 2010. All patients were invited 
to participate. We include postmenopausal Mexican 
mestizo ethnic women, without previous diagnosis of 
osteoporosis or treatment. Women were considered 
postmenopausal if they had not menstruated within 
the last 12 months before the examination. Body 
height and weight were measured at baseline exami-
nation in a standing position without outer clothes 
and without shoes. Height and weight were used 
to calculate BMI (kilograms per meter squared). A 
structured validated questionnaire that include osteo-
porosis related risk factors  was administered by the 
physician.
FRAXTM scores were calculated manually from 
the FRAXTM (http://www.shef.ac.uk/FRAX). The 
Mexican version of FRAXTM was used for all sub-
jects. The 10-year probabilities of major osteopo-
rotic and hip fracture were recorded for FRAXTM; all 
calculation was performed without BMD value. The 
FRAXTM tool was designed to be used with central 
DXAS data, and we used it following the recommen-
dation of World Health Organization for using this 
tool when the data of central DXAS is not available. 
We consider women at risk those with 10-year major 
osteoporotic fracture probability of greater than or 
equal to 20 %, and/or 3 % for hip fracture following 
the recommendation of NOF.
Measurements of calcaneal BMD (g/cm2) was 
performed using peripheral DXAS, PIXI (Peripheral 
Instantaneous X-ray Imager, GE Lunar Corporation, 
Madison, WI, USA). The World Health Organization 
defi nitions of osteopenia (BMD T-score between −1 
and −2.5) and osteoporosis (BMD T-score less than or 
equal to −2.5) were applied and the calcaneal BMD.
Statistical analysis was performed using SPSS 
software V17 (Microsoft, San Diego, CA). Descrip-
tive statistics are presented as mean values and stan-
dard deviation. Variables were tested for normality 
using the Kolmogorov-Smirnov test. In relations with 
a normality distribution, Pearson’s or Spearman’s cor-
relation coeffi cients were calculated to examine the 
relationship between variables. Student t-test or the 
Mann-Whitney U-test was used for comparisons of 
two groups. Kappa index was calculated for evaluate 
the concordance between both methods.
Evaluación del riesgo de fracturas osteoporóticas. Opciones a la densitometría central
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The study received ethical approval by the local 
Institutional Review Board, and all subjects gave writ-
ten informed consent to participate.
Results
A total of 332 postmenopausal women were included. 
Mean age was 60 ± 8.7 years. Mean menopause age 
was 50 ± 2.1 years. Mean BMI was 28.68 ± 4.24 kg/m2. 
Two hundred fi fty eight (73.4 %) patients were obese 
or overweight.
Thirteen women (3.9 %) were considered at risk of 
having osteoporotic fracture in a 10 years period, and 40 
(12 %) for hip fracture using the FRAXTM tool accord-
ing to the NOF recommendations. Thirteen women in 
risk of osteoporotic fracture in a ten years period were 
also considered at risk for hip fracture. The most com-
mon risk factor for osteoporosis was premature meno-
pause present in 46 % of the patients (table I).
In pDXAS according to the World Health Organiza-
tion classifi cation, 19 women (5.7 %) fell in the range 
of osteoporosis, 172 (51.8 %) in osteopenia and 141 
(42.5 %) with normal T-score. Pearson correlation was 
performed, obtaining a negative correlation between 
BMD and age (r2 of – 0.445, p < 0.001), likewise found 
a positive correlation between BMD and weight (r2 of 
0.209, p < 0.001).
Only eight patients were defi ned as high 10 years 
risk for fracture with FRAXTM and also were cat-
egorize with osteoporosis according World Health 
Organization with pDXAS. The kappa index identify-
ing women in risk to develop a osteoporosis related 
fracture in the next 10 years period with the two tools 
(FRAXTM and pDXAS) was  = 0.203. When we 
exclude the eight patients that were considered in risk 
in both methods, those with diagnostic of osteoporo-
sis according pDXAS seems to be younger than those 
categorized at high risk according FRAXTM (table II).
Discussion
In the study we described the prevalence of osteopo-
rotic risk factors and the characteristics of bone mineral 
density, in post menopausal women without previous 
diagnostic or treatment of osteoporosis, who attend to 
a primary care level center, where central DXAS of hip 
and lumbar spine is not available. We use two cheap 
tools (FRAXTM and pDXAS to look for those women 
who were in high risk to develop a osteoporotic frac-
ture. In our sample population the tools seems to iden-
tify different patients. Due the cross-sectional design 
of this study, the aim was neither to evaluate nor to 
compare the effectiveness of both tools for predicts 
osteoporotic fractures. The aim of this study was to 
describe the results of osteoporotic risk factors evalu-
ation using two different tools, in a postmenopausal 
women population who attend to a primary care center 
where central DXAS is not available.
Osteoporosis and fragility fractures have recently 
become a focus of research in Mexico, where one out 
of twelve Mexican women and one out of four Mexi-
can men over 50 years of age will sustain a hip frac-
ture in the remaining years of their life.12 According a 
study in our health system, the cost of hospitality care 
of hip fracture in postmenopausal women was more 
than 36 million dollars in two years.13 Identifi cation 
of individuals at high risk of osteoporotic fracture is 
important to develop strategies to reduce the burden 
of such fractures. Moreover preliminary calculations 
estimate that the number of dedicated (DXAS) units 
required to assessment the population at risk is at 
least, eight per each million of inhabitants. Unfortu-
nately, neither the most developing countries meet this 
requirement.14 So it is advisable to promote research 
on the appropriate use of cheaper and portable diag-
nostic alternatives, and others tools.
A number of authors have investigated the ability of 
peripheral devices to measure the density and micro-
architectural properties of bone.8,15,16 The peripheral 
devices measures had not a close correlation with cen-
tral BMD measures by central DXAS. The measure-
ments obtained with them are not the same to defi ne 
osteoporosis according World Health Organization 
criteria.17 However pDXAS is an accepted method of 
assessing skeletal status, and because of the advantage 
of low cost and portability, pDXAS is an alternative 
tool for identifying individuals at risk of fracture.10 The 
heel pDXAS use for measure BMD, when is obtained 
with appropriate triage thresholds, can help to identify 
patients suitable for fracture prevention treatment.18 It 
has been shown that peripheral and central measures 
are equally used in the clinical risk fractures for osteo-
porosis estimation.9
In our study we found that the combined percent-
age of patient with osteopenia-osteoporosis is almost 
60 % in our population; This seems to be lower that 
reported by Lago Acosta19 using the same method in 
Mexican population; he reported approximately of 
80 % of patients with osteopenia-osteoporosis. The 
difference between both studies is that in our study 
we only considered patients without previous diagno-
sis or treatment for osteoporosis, so we estimate the 
incidence not the prevalence of the disease. In the case 
of Lago Acosta study, it was made in open population 
from different care units considering both sex (men 
and women) with or without previous diagnosis or 
treatment of osteoporosis. The same explanation could 
be applied to the different fi ndings reported by Rojano 
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Mejía20 using central DXAS in which previous diag-
nosis or treatment of osteoporosis were not consider.
Historically, fracture risk assessment in individu-
als without a clinical diagnosis of osteoporosis based 
upon established fragility fractures was determined 
only by BMD measurements. Recently, the use of 
clinical risk factors has been shown to enhance the 
performance of BMD in the prediction of hip and 
major osteoporotic fractures.21 
The World Health Organization fracture risk assess-
ment tool FRAXTM allows estimation of individual 
10-year major osteoporotic and hip fracture probabili-
ties.6 Analyses have confi rmed that there is improve-
ment in fracture prediction using BMD and clinical 
risk factors together compared with using either BMD 
alone or clinical risk factors only. This has led to broad 
endorsement of FRAXTM and its integration into clini-
cal practice guidelines.22,23 For example, a 10-year 
major osteoporotic fracture probability greater than 
or equal to 20 % is considered in high risk and it is 
an indication for intervention according to the NOF 
of the United States and Osteoporosis Canada Group. 
The NOF also recommends that a 10-year hip fracture 
probability greater than or equal to 3 % is considered 
for clinical intervention, in addition to those with any 
BMD measurements in the osteoporotic range and 
those with prior spine or hip fractures.24
The World Health Organization recommends that 
FRAXTM tool could be used with out the measure-
ment of BMD in those places where central DXAS 
is not available. Recent publication has shown that 
FRAXTM tool used with or without BMD has simi-
lar performance.25 In Mexican health services pri-
mary care units represents approximately 95 % of all 
medical services.26 Primary care level decisions have 
a big impact in Mexican health costs. Osteoporosis 
treatment represents a big challenge for the most pri-
mary care physicians; decision of treatment has to be 
done most of the time without information of central 
DXAS measures. 
According to results from our study the using of 
pDXAS only, suggested that 5.7 % of our population 
will need medical preventive intervention. When we 
use only Mexican FRAXTM without the measurement 
of BMD according of WHO recommendation 12 % of 
the patient perhaps could be considered for interven-
tion. There is a lack of concordance between tools, 
only eight patients (2.4 %) would qualify for interven-
tion in both tools. The difference found between both 
tools could be related that FRAXTM estimates the risk 
in a 10 years period using several risk factors, and the 
pDXAS estimates the bone status in the current time. 
In our study, patients found in ten years risk according 
to FRAXTM seem to be older than the patient found 
with osteoporosis in pDXAS.
Some authors had mentioned several limitations 
for FRAXTM. Some of those limitations are: may 
only be used in untreated patients, poor defi nition of 
secondary osteoporosis, relationship between BMI 
and mortality, variability in fracture rates.27 One of 
the big concerns is the ethnicity variability. New 
data had been published with different countries 
experiences.28,29 This variability could be important, 
as shown by Nasser30 who compare South Califor-
nian women of  Mexican descent using US Hispanic 
and Mexican databases. Differences were noted in 
the absolute number of hip fracture subjects at risk. 
However FRAXTM is a major achievement in terms 
of our understanding of measuring fracture risk. It is 
the only model based on extensive data on multiple 
cohorts with and without BMD that has been vali-
dated in additional cohorts.
Table I Characteristics of 332 patients with osteoporotic risk fracture evaluation 
Age (years) 60.07 ± 8.73
Weight (kg) 66.31 ± 10.04
Body mass index 28.68 ± 4.27
Bone mineral density (g/cm2) 0.466 ± 0.11
n %
Previous fracture  83  25.0
Parent fractured hip  34  10.2
Current smoking  27  8.1
Glucocorticoids  12  3.6
Rheumatoid arthritis  43  13.0
History of long-standing hyperthyroidism  14  4.2
Alcohol 3 or more units/day  5  1.5
Type I diabetes  4  1.2
Hypogonadism or premature menopause (< 45 years)  154  46.4
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FRAXTM could help clinicians to identify individu-
als who need osteoporosis preventive interventions and 
also individuals who do not need osteoporosis treat-
ment. There are not prospective studies that compare the 
cost effectiveness of treat patient using these methods 
in developing countries. Interventions patients with risk 
of osteoporotic fracture in primary care level, remains 
to be a big challenge for health systems authorities.
We considered that results showed with both tools 
could be useful to identify patients at risk of having 
a osteoporotic fractures, however the patients found 
seems to be different, in each method the appropri-
ate intervention should be individualized according 
to patient characteristics and local health resources. 
Future prospective studies needs to be done to see 
the real impact of the reduction of fractures using this 
tools in primary care level.
Conclusions
In the present study using two different approaches 
that could be more commonly available in primary 
care units. Both tools are easy and convenient to use 
in primary care units, however they seems to identify 
different patients. The limitations of this study is the 
cross sectional design and that was made only in one 
primary care unit. The strength of this study is that 
is the fi rst one that compare this two approaches in 
primary care level in post-menopausal women without 
previous diagnosis or treatment of osteoporosis. 
Confl ict of interest disclosure: the International Committee of 
Medical Journal Editors form for disclosure of potential confl icts 
of interest has been completed and delivered by the authors. It 
hasn’t been reported any confl ict in regards to this article.
Table II Difference in women considered in high risk of osteoporotic fractures according each tool
FRAXTM
(n = 32)
DXAS
(n = 11)
p*
Age (years) 72.6 ± 1.1 62.4 ± 3.2  < 0.001
Weight (kg) 63.6 ± 1.6 62 ± 2.8  0.69
Body mass index 27.5 ± .01 28.4 ± .79  0.45
T-score –1.47 ± 0.12 –2.7 ± 0.04  < 0.001
Z-score –0.22 ± 0.13 –1.9 ± 0.14  < 0.001
Bone mineral density (g/cm2) 0.416 ± 0.014 0.278 ± 0.004  < 0.001
DXAS = dual energy X-ray absorptiometry scan
Patients who were positives in both tools were excluded for this analysis
*p value was calculated with Student-t test or Mann-Whitney U-test as appropriate
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